Medicared For All Logo

Jumana Chatiwala in Sparta, New Jersey

Home New Jersey Sparta

Jumana Chatiwala has Hematology as her primary medical specialty. Their primary office is: 89 Sparta Ave in Sparta, New Jersey.

They're a part of the: Regional Cancer Care Associates Llc medical group which has around 111 members. You can call their office at 973-726-0005 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 1996 (around 28 years of experience). They are listed as doing telehealth appointments.


Jumana S Chatiwala Office Phone and Directions

Jumana Chatiwala
Regional Cancer Care Associates Llc
89 Sparta Ave
Sparta, New Jersey 07871
973-726-0005


Patient Ratings
Please rate your experience with Jumana Chatiwala below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 973-726-0005


Enter a starting address:


Healthcare Info for Jumana Chatiwala

Additional Medical Specialties Include:
MEDICAL ONCOLOGY

Medical School: Sorry, her university is not listed
Graduation Year: 1996
The Primary Medical Specialty for Jumana Chatiwala is listed as: Hematology
Approximate Years of Experience: 28
PAC (PECOS ID)#: 6406946730
NPI #: 1215066980
NPI Created On: 03/05/2007
NPI Last Updated Listed as: 02/18/2015
Primary Taxonomy Code: 207R00000X
License Number:
25MA07765000
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • AmeriHealth New Jersey
  • Blue Cross Blue Shield
  • Oscar Garden State Insurance Corporation
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Bone marrow biopsy and aspiration
  3. Complete blood cell count (red cells, white blood cell, platelets), automated test
  4. Hydration infusion into a vein 31 minutes to 1 hour
  5. Hydration infusion into a vein
  6. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  7. Infusion into a vein for therapy, prevention, or diagnosis
  8. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  9. Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion
  10. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  11. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
  12. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
  13. Infusion of different chemotherapy drug or substance into a vein
  14. Infusion of chemotherapy into a vein up to 1 hour
  15. Infusion of chemotherapy into a vein
  16. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
  17. Irrigation of implanted venous access drug delivery device
  18. Therapeutic removal of whole blood to correct blood level imbalance
  19. New patient office or other outpatient visit, typically 45 minutes
  20. New patient office or other outpatient visit, typically 60 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787993669

Being Disputed:: No

Product Related: No


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787993671

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818616985

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832161133

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832161181

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01


Payments Total: $14

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783731631

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Hematology

Name of Drug #1: REBLOZYL

Open Associated Drug #1: 59572-711-01


Payments Total: $12

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783731633

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Hematology

Name of Drug #1: REBLOZYL

Open Associated Drug #1: 59572-711-01


Payments Total: $13

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783657955

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $15

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783657981

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812633219

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15


Providers in Regional Cancer Care Associates Llc

1.May Abdo-matkiwsky Do

30 Prospect Ave
Hackensack Nj 07601-1915
Regional Cancer Care Associates Llc
Hematology/oncology

2.May Abdo-matkiwsky Do

89 Sparta Ave
Sparta Nj 07871-1791
Regional Cancer Care Associates Llc
Hematology/oncology

3.Manmeet Ahluwalia

57 Kent Rd
Howell Nj 07731-2452
Regional Cancer Care Associates Llc
Hematology/oncology

4.Manmeet Ahluwalia

40 Bey Lea Rd
Toms River Nj 08753-2900
Regional Cancer Care Associates Llc
Hematology/oncology

5.Kaleem Ahmad

30 Prospect Ave
Hackensack Nj 07601-1915
Regional Cancer Care Associates Llc
Hematology/oncology

6.Kaleem Ahmad

210 Route Us 9 S 106
Marmora Nj 08223-1271
Regional Cancer Care Associates Llc
Hematology/oncology

View all 111 members of Regional Cancer Care Associates Llc medical group